ARCHIVES

James Doroshow Named NCI Deputy Director, Clinical Research

This article is from The Cancer Letter archive.

Vol. 37 No. 23 | June 10, 2011

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

Budget Presents “Themes,” Not Individual NIH Institutes.

April 13, 2001

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

Toxicology Program Seeks Comment On Substances.

March 23, 2001